IPC & Chinese Psoriasis Network Symposium: Psoriasis in the Post-Biologics Era

Agenda

Welcome and About IPC
Hervé Bachelez, MD, PhD, France

Advances in Psoriasis Research
Johann Gudjonsson, MD, PhD, United States

New Treatment Targets for Psoriasis
Hervé Bachelez, MD, PhD, France

Sustainable Disease Control
Paolo Gisondi, MD, Italy

Early Intervention
Christopher Griffiths, OBE, MD, FMedSci, United Kingdom

COFFEE BREAK

Metabolism and Psoriasis
Xiang Chen, MD, PhD, China

How to Discover Psoriasis Scientific Research Topics from Clinical Practice
Yuling Shi, MD, PhD, China

Skin-X Axis: From Psoriasis to Psoriatic Diseases
Xiaoyong Man

Novel Insights on Psoriasis Pathogenesis
Liangdan Sun, MD, PhD, China

Closing and Adjourn
Xuejun Zhang, MD, PhD, China
Min Zheng, MD, China

Program Chairs

Christopher Griffiths, OBE, MD, FMedSci

University of Manchester and King’s College London

London, United Kingdom

IPC Honorary Founder

Bio

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Monday, April 27, 2026

Highlights from the 2026 American Academy of Dermatology (AAD) Annual Meeting: Diagnostic Complexity, Therapeutic Advances, and Emerging Research

What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and late-breaking research from leading experts.

Tuesday, April 28, 2026

International Collaboration Announced to Improve Care for Psoriasis and Psoriatic Arthritis in Latin America

A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.

Monday, April 27, 2026

Next Generation of Leaders: 2025 IPC Fellows Transition to Jr. Councilors

IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.

Wednesday, April 29, 2026

IPC Welcomes New Councilors Dr. Mari Løset and Dr. Maxwell Sauder

The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.

Tuesday, April 21, 2026

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

IPC & Chinese Psoriasis Network Symposium: Psoriasis in the Post-Biologics Era

IPC AND CHINESE PSORIASIS ASSOCIATION | TANGSHAN, HEBEI, CHINA

Agenda

Program Chairs

Hôpital Saint-Louis, Imagine Institute for Human Genetic Diseases, Paris Cité University

Paris, France

Vice President & President-Elect

Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

IPC Councilor

Anhui Medical University

Hefei, China

IPC Councilor

Program Faculty

Dept. Dermatology, Xiangya Hospital, Central South

Changsha, China

University of Verona

Verona, Italy

IPC Councilor

University of Manchester and King’s College London

London, United Kingdom

IPC Honorary Founder

University of Michigan, Department of Dermatology

Ann Arbor, Michigan, United States

IPC Board Member

The Second Affiliated Hospital Zhejiang University School of Medicine

Hangzhou, China

IPC Councilor

Shanghai Skin Disease Hospital, Tongji University School of Medicine

Shanghai, China

IPC Councilor

Health Science Center of North China University of Science and Technology

Hebei Province, China

IPC Councilor

What's New

Recent Advances in Psoriasis: A Year in Review

Monday, April 6, 2026